You have 1 action to finish to complete your account. Customize your experience by selecting your interests on the Personalization page
No matches

7 search results for: ige

<b>IgE</b> as a Biomarker for Type 2 Asthma
expert video

IgE as a Biomarker for Type 2 Asthma

Pulmonology
Dr. Jonathan Corren describes the diagnostic, predictive, and prognostic role of IgE as a biomarker of type 2 inflammation in asthma.
View more
PRURITO CRÓNICO: EL OR<b>IGE</b>N: DEBATE Y DISCUSIÓN
expert video

PRURITO CRÓNICO: EL ORIGEN: DEBATE Y DISCUSIÓN

Dermatology
No se pierda esta nueva escala de ADVENT ON TOUR desde Barcelona sobre prurito crónico.
View more
Or<b>ige</b>n y clínica del prurito
expert video

Origen y clínica del prurito

Dermatology
No se pierda esta nueva escala de ADVENT ON TOUR desde Barcelona sobre prurito crónico.
View more
Impact of Advanced Systemic Therapies on Disease Control in AD
expert video

Impact of Advanced Systemic Therapies on Disease Control in AD

Dermatology
Dr. Simpson discusses impact of advanced systemic therapies in AD, and the link between inhibition of type 2 inflammation and reduced IgE levels.
View more
Type 2 Inflammation Underpins Pediatric Severe Asthma
Infographic

Type 2 Inflammation Underpins Pediatric Severe Asthma

Pulmonology
Learn about the role type 2 inflammation plays in the burden and pathophysiology of severe asthma in pediatric patients.
View more
The Current and Potential Future Roles of Biomarkers and Precision Medicine in CSU Clinical Management
expert video

The Current and Potential Future Roles of Biomarkers and Precision Medicine in CSU Clinical Management

Dermatology
Drs. Kim and Saini explore the potential future roles of biomarkers and precision medicine in CSU clinical management.
View more
IL-4 Contributes to Systemic Type 2 Inflammation in AD
expert video

IL-4 Contributes to Systemic Type 2 Inflammation in AD

Dermatology
In this highlight video from the ADVENT AD symposium held at EADV’s 2024 Annual Meeting in Amsterdam, Dr. Stephan Weidinger discusses how IL-4 contributes to systemic type 2 inflammation in AD via several mechanisms, including T cell differentiation, B cell activation and IgE generation, and T regulatory cell inhibition.
View more

ADVENT is a global medical education non-promotional program by Sanofi and Regeneron. This website is intended only for duly authenticated healthcare professionals in Algeria, Argentina, Australia, Austria, Bahrain, Belgium, Brazil, Bulgaria, Canada, Chile, China, Colombia, Costa Rica, Croatia, Czech Republic, Denmark, Dominican Republic, Ecuador, Egypt, Estonia, Finland, France, Germany, Greece, Guatemala, Hong Kong, Hungary, Iceland, India, Israel, Italy, Japan, Kuwait, Latvia, Lebanon, Lithuania, Macau, Malaysia, Norway, Oman, Panama, Peru, Poland, Portugal, Qatar, Romania, Saudi Arabia, Singapore, Slovenia, South Africa, South Korea, Spain, Sudan, Sweden, Switzerland, Taiwan, Thailand, The Netherlands, Turkey, United Arab Emirates, or the United States of America.

For healthcare professionals in Algeria: Please read the additional Terms of Use.

Sanofi | Regeneron Logo

© 2025 Sanofi and Regeneron Pharmaceuticals, Inc.

All rights reserved.
MAT-GLB-2302957 v3.0 11/2023

All Rights Reserved.

Sanofi and Regeneron are global leaders in pharmaceutical development, each with a long history of supporting frontline physicians to improve human health and reduce the burden of disease. Driven by the same commitment to patients and their families, Sanofi and Regeneron have partnered to take on type 2 inflammation and the range of chronic conditions in which excessive inflammation plays a role.

Country/region: SpainChange country/region